Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain

NCT05986292 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT05986292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05986292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Recruiting
Start date
January 30, 2020
Completion date
April 30, 2027
Enrollment
10,000 (estimated)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain, diabetic neuropathic pain, osteoarthritis, knee